J B Chemicals & Pharmaceuticals Ltd accepted the resignation of Bhushan Sachdev from the position of Executive Vice President – Supply Chain Management, effective from the close of business hours on June 12, 2026. The company confirmed that the cessation was due to personal reasons, following a request from BSE Limited to submit a fresh corporate announcement regarding the change in senior management personnel.

The disclosure was submitted in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing referenced the SEBI Master Circular bearing reference no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and No. CIR/CFD/CMD/4/2015 dated September 09, 2015.

The following table details the key information regarding the management change:

The filing was submitted by Sandeep Phadnis, Vice President – Secretarial and Company Secretary. J B Chemicals & Pharmaceuticals Ltd has requested the exchange to take the information on record.

J.B. Chemicals & Pharmaceuticals Limited has scheduled its 50th Annual General Meeting (AGM) for June 17, 2026, at 3:00 p.m. IST via Video Conferencing. The meeting will transact business including the adoption of financial statements for the year ended March 31, 2026, and the declaration of dividends. Shareholders holding shares as on the record date of May 29, 2026, will be eligible to receive the dividend payout.

The board has proposed a final dividend of ₹9.30 per equity share for the financial year 2025-26. Additionally, the meeting will seek confirmation for an interim dividend of ₹12.70 per equity share already paid during the financial year. If approved, the final dividend is scheduled to be paid on or after June 19, 2026, subject to tax deduction at source as per the Income Tax Act, 2025.

Agenda and Appointments

The AGM will consider the adoption of the audited financial statements and consolidated financial statements for the year ended March 31, 2026. Shareholders will also vote on the re-appointment of Mr. Amal Kelshikar (DIN: 06378987), who retires by rotation and is eligible for re-appointment. Mr. Kelshikar currently oversees the India business of Torrent Pharmaceuticals Limited and brings over 32 years of experience in strategic planning and marketing.

Annual Report and Notice Dispatch

In compliance with Regulation 36(1)(a) and 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has dispatched the Notice of the 50th AGM along with the Integrated Annual Report for FY 2025-26. Members with registered email addresses received these documents electronically. For shareholders whose email addresses are not registered with the Registrar & Share Transfer Agent or Depository Participants, the company has dispatched letters providing the web-link to access the Integrated Annual Report. The company has requested these shareholders to update their email details to ensure easy access to future documents.

E-Voting and Participation Details

Remote e-voting facilities will be available from June 14, 2026, at 9:00 a.m. to June 16, 2026, at 5:00 p.m. Shareholders holding shares as on the cut-off date of June 10, 2026, are eligible to cast their votes. The company has engaged Central Depository Services (India) Limited (CDSL) to facilitate the electronic voting process.

Shareholders holding physical shares are requested to ensure their KYC details, including PAN and bank account information, are updated to receive dividends electronically. The company has advised members to utilize the Electronic Clearing System (ECS) for seamless dividend receipt.